Topadur Pharma Ag Is A Clinical Stage Biopharmaceutical Company Based In Schlierenswitzerlandfounded In 2015The Company Specializes In Developing Innovative Therapies For Aging Related And Rare Diseases Using Its Proprietary Dualtopa C Technology Platformthis Platform Targets The Cgmp Enzyme Regulation System To Enhance Microcirculationpromote Tissue Regenerationand Address Oxygen Deficiency In Affected Tissues Topadur Focuses On Regenerative Medicineoncologyophthalmologyand Medical Aestheticsits Pipeline Includes Candidates For Chronic Woundsglaucomacolorectal Cancerand Alopeciathe Company Is Preparing For An Ipo In Switzerland In 2024 25 And Has Received Funding From Organizations Like Innosuissewith A Leadership Team That Includes Experienced Professionals In Biomedical Research And Pharmaceutical Developmenttopadur Is Committed To Advancing Therapies That Meet High Unmet Medical Needs
